Teva chemotherapy side-effect drug Lonquex gets European nod

– This approval provides the regulatory framework for the commercialization of Lonquex in all 28 EU countries. – Illustration   Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced today More...